Abstract
The advent of monoclonal antibodies has opened a new area of breast cancer therapy, and because of unique aspects compared to conventional therapy new approaches have to be defined, and new problems addressed. Monoclonal antibodies have to be selected specifically for therapy, ideal characteristics have to be defined, conjugates must be selected, conjugation methods must be evaluated, and appropriate target antigens have to be identified. One aspect of the latter that must be taken into consideration is the complexity and cell heterogeneity in expression of most antigens that have an appropriate tissue or tumor cell specificity for therapy. This paper will address the question of antigenic heterogeneity in approaching the use of monoclonal antibodies for therapy of breast cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R. L. Ceriani, K. E. Thompson, J. A. Peterson and S. Abraham, Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule. Proc. Natl. Acad. Sci. USA 74:582–586(1977).
R. L. Ceriani, J. A. Peterson and E. W. Blank, Variability in surface antigen expression of human breast epithelial cells cultured from normal breast, normal tissue peripheral to breast carcinoma, and breast carcinomas. Cancer Res. 44:3033–3039 (1984).
R. L. Ceriani, J. A. Peterson, J. Y. Lee, R. Moncada and E. W. Blank, Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule. Somat. Cell Genetic. 9:415–427 (1983).
H. P. Kalofonos and A. A. Epenetos, Antibody guided diagnosis and therapy of patients with breast cancer, in: “Immunological Approaches to the Diagnosis and Therapy of Breast Cancer,” R. L. Ceriani, ed., Plenum Press,New York, p. 245–257 (1987).
S. J. Gendler, J. M. Burchell, T. Duhig, D. Lamport, R. White, M. Parker and J. Taylor-Papadimitriou, Cloning of partial cDNA enciding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium, Proc. Natl. Acad. Sci. US. 84:6060–6064 (1987).
J. A. Peterson, J. C. Bartholomew, M. Stampfer and R. L. Ceriani, Analysis of expression of human mammary epithelial antigens in normal and malignant breast cells at the single cell level by flow cytofluorimetry, Exp. Cell Biol. 49:1–14 (1981).
R. L. Ceriani, E. W. Blank and J. A. Peterson, Experimental immunotherapy of human breast carcinomas implanted in nude mice with a mixture of monoclonal antibodies against human milk fat globule components, Cancer Res. 47:532–540 (1987).
R. L. Cerianiand W. Blank, Experimental therapy of human breast tumors with 131I labeled monoclonal antibodies prepared against the human milk fat globule, Cancer Res. 48:4664–4672 (1988).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Peterson, J.A., Blank, E., Zoellner, C., Enloe, S., Walkup, G., Ceriani, R.L. (1989). Cell Heterogeneity and Complexity of Breast Epithelial Surface Antigens Expression and Moab Therapy. In: Ceriani, R.L. (eds) Breast Cancer Immunodiagnosis and Immunotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1296-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1296-4_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1298-8
Online ISBN: 978-1-4757-1296-4
eBook Packages: Springer Book Archive